← Eichor
Condition: Metabolic Associated Fatty Liver Disease Mafld Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Metabolic Associated Fatty Liver Disease Mafld

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
Phase N/A · 1 location(s) · Chongqing Medical University · NCT05974904Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China
Phase N/A · 1 location(s) · Wuxi Hisky Medical Technology Co Ltd · NCT05597709A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · 563 location(s) · Eli Lilly and Company · NCT07165028Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improv
Phase 2 · 2 location(s) · Li Lab,MD · NCT06798948The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older Adults
NA · 1 location(s) · Fujian Provincial Hospital · NCT06717828Effect of CoQ10 on the Outcome of MAFLD Patients
Phase 2 · 1 location(s) · Ain Shams University · NCT05984745Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis
NA · 1 location(s) · Universitas Diponegoro · NCT06585982Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
NA · 1 location(s) · Phenomen Pharma · NCT07068191Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients
Phase N/A · 1 location(s) · Tanta University · NCT06503068Efficacy and Safety of Rifaximin in Treating MAFLD
EARLY_Phase 1 · 1 location(s) · Shanghai Changzheng Hospital · NCT07185932Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD
Phase N/A · 22 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07632677Dihydroartemisinin for MAFLD
Phase 1/Phase 2 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07679542Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
Phase N/A · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT07658755
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.